Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Harvest One Reaches Supply Agreement With Canopy Growth's Spectrum Therapeutics' Online Medical Store

Harvest One Cannabis Inc. (OTCQB: HRVOF) (TSXV:HVT) strengthened its position in the cannabis-infused market through a supply agreement with Canopy Growth Corporation (NASDAQ: CGC).

Benzinga

Insurance Stocks Moving In Friday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices

Arkansas has accused Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Sanofi SA (NASDAQ:SNY), and three of the largest pharmacy benefit managers (PBMs) of artificially driving up insulin prices. The complaint, filed by Arkansas Attorney General Leslie Rutledge, alleges the defendants devised a scheme in which the Big Pharmas would "artificially and willingly raise their…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

5 American Stocks To Buy To Bet On An Economic Rebound: From Amazon To Coca-Cola

U.S. GDP dropped 1.4% in the first quarter of 2022, and the SPDR S&P 500 ETF Trust (ARCA: SPY) is down 16.3% year-to-date as investors become increasingly concerned about the possibility of a U.S. recession in 2022.

Benzinga

Mid-Day Market Update: Crude Oil Rises 3.5%; FIGS Shares Slide

U.S. stocks traded higher midway through trading, with the Nasdaq Composite adding more than 3% on Friday.

Benzinga

Stocks That Hit 52-Week Lows On Friday

On Friday, 153 companies set new 52-week lows.

Benzinga

iSun Earnings Preview

iSun (NASDAQ:ISUN) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that iSun will report an earnings per share (EPS) of $-0.02.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Earnings Outlook For Eastside Distilling

Eastside Distilling (NASDAQ:EAST) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Eastside Distilling will report an earnings per share (EPS) of $-0.18.

Benzinga

Orbital Energy Group's Earnings Outlook

Orbital Energy Group (NASDAQ:OEG) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Orbital Energy Group will report an earnings per share (EPS) of $-0.05.

Benzinga

Earnings Outlook For Pyxis Tankers

Pyxis Tankers (NASDAQ:PXS) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Pyxis Tankers will report an earnings per share (EPS) of $-0.02.

Benzinga

6 Analysts Have This to Say About Avis Budget Gr

Avis Budget Gr (NASDAQ:CAR) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Preview For Mind Medicine

Mind Medicine (NASDAQ:MNMD) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Mind Medicine will report an earnings per share (EPS) of $-0.05.

Benzinga

Earnings Preview: Ryanair Holdings

Ryanair Holdings (NASDAQ:RYAAY) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Ryanair Holdings will report an earnings per share (EPS) of $-1.02.

Benzinga

Earnings Outlook For Greenland Technologies

Greenland Technologies (NASDAQ:GTEC) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Greenland Technologies will report an earnings per share (EPS) of $0.09.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Earnings Preview For Kala Pharmaceuticals

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Kala Pharmaceuticals will report an earnings per share (EPS) of $-0.36.

Benzinga

Preview: Gracell Biotechnologies's Earnings

Gracell Biotechnologies (NASDAQ:GRCL) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Gracell Biotechnologies will report an earnings per share (EPS) of $-0.21.

Benzinga

Earnings Outlook For Compugen

Compugen (NASDAQ:CGEN) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Compugen will report an earnings per share (EPS) of $-0.13.

Benzinga

Earnings Preview For Wix.com

Wix.com (NASDAQ:WIX) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Wix.com will report an earnings per share (EPS) of $-0.64.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

56 Stocks Moving In Friday's Mid-Day Session

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.

Benzinga

Analyst Ratings for Prometheus Biosciences

Analysts have provided the following ratings for Prometheus Biosciences (NASDAQ:RXDX) within the last quarter:

Benzinga

Impel NeuroPharma Earnings Preview

Impel NeuroPharma (NASDAQ:IMPL) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Impel NeuroPharma will report an earnings per share (EPS) of $-1.05.

Benzinga

Peering Into Plug Power's Recent Short Interest

Plug Power's (NASDAQ:PLUG) short percent of float has fallen 3.34% since its last report. The company recently reported that it has 63.29 million shares sold short, which is 12.45% of all regular shares that are available for trading.

Benzinga

Morgan Stanley Maintains Overweight Rating for CyberArk Software: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of CyberArk Software (NASDAQ:CYBR) and lower its price target from $191.00 to $172.00. Shares of CyberArk Software are trading up 9.01% over the last 24 hours, at $131.36 per share.

Benzinga

SVB Leerink Maintains Outperform Rating for Olink Holding: Here's What You Need To Know

SVB Leerink has decided to maintain its Outperform rating of Olink Holding (NASDAQ:OLK) and lower its price target from $25.00 to $20.00. Shares of Olink Holding are trading up 5.12% over the last 24 hours, at $11.50 per share.

Benzinga

Greenlane Expands Into Latin American Cannabis Market Via Agreement With Universal Distribution

Greenlane Holdings, Inc. (NASDAQ: GNLN) has entered into a distribution agreement with Universal Distribution LATAM LLC to distribute its proprietary portfolio of house brands in Latin America.

1 … 458 459 460 461

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

CVS Health Corporation

61 stories

Eli Lilly And Co

52 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.